Patient Safety Organizations: Voluntary Delisting, 75471-75472 [2010-30263]
Download as PDF
<![CDATA[
mstockstill on DSKH9S0YB1PROD with NOTICES
Federal Register / Vol. 75, No. 232 / Friday, December 3, 2010 / Notices
discussed in the Federal Register Notice
and background paper that
accompanied the public posting of the
initial, recommended core set (https://
www.ahrq.gov/chip/
chipraact.htm#Core), not all CHIPRA
criteria were able to be met for the
initial core set. Public comments on the
initial, recommended core set, and an
expert meeting on measure criteria for
the CHIPRA PQMP (https://
www.AHRQ.gov/chipra/#Expert)
provided additional insights into
potential priorities for the PQMP. The
combination of these efforts and events
led to the identification of the following
potential priorities for measure
enhancement and development of new
measures:
1. Development or enhancement of
methods to:
a. Standardize measures across all
payers, programs, and providers, public
and private, as appropriate, to ensure
that comparisons are valid.
b. Assess disparities in quality by
race, ethnicity, socioeconomic status,
geographic region and residence, and
special health care needs, for example
by developing new measurement
methods or enhancing existing
measurement methods.
c. Adjust for risk by enrollment
duration.
d. Stratify or adjust for risk by depth
and breadth of coverage.
e. Stratify or adjust for risk by medical
conditions, including severity and
acuity.
f. Capitalize on current and coming
investments in health information
technology (e.g., patient and procedure
registries, electronic health records,
health information exchanges,
interoperability), including meaningful
use criteria under the American
Recovery and Reinvestment Act
(ARRA).
g. Increase State programs’ and CMS’s
ability to rely on non-Medicaid and
CHIP data sources through improvement
in public health sector measurement
(e.g., birth certificate data;
immunization surveys).
h. Come to consensus on the meaning
and application of ‘‘evidence-based’’ in
the context of healthcare quality
measurement for children.
i. Incorporate patient and family
perspectives into measurement to
increase understandability.
2. Development or enhancement of
measures in key topic areas:
a. Most integrated healthcare settings.
b. Availability of services.
c. Duration of enrollment as a
standalone measure.
d. Measures of the content (quality) of
care now typically measured as broad
VerDate Mar<15>2010
16:09 Dec 02, 2010
Jkt 223001
utilization categories (e.g., prenatal,
postpartum, newborn care (including
breastfeeding support), well-child and
adolescent well-care visits, screening
services, and follow-up visits for
chronic conditions and related
medications).
e. Specific care settings and
conditions:
i. Perinatal care (e.g., family planning
clinics, obstetric and gynecological care,
birth centers).
ii. Quality of mental/behavioral health
and substance abuse services, including
prevention and treatment services,
across all settings.
iii. Quality of care in settings beyond
traditional medical care settings (e.g.,
for screening, diagnostic services and
therapies).
iv. Inpatient settings (including
specialty inpatient settings).
v. Specialty care for child conditions
and diseases.
vi. Care transitions for patients
transitioning within and across health
care settings.
vii. Additional measures related to
family experiences of care (e.g., child or
adolescent self-reports; perinatal
experiences of care; inpatient
experiences)
viii. Health outcome measures (e.g.,
measures of patient and population
health or other outcomes of
healthcare).2
ix. Structural measures (e.g., measures
of system design features that are
causally linked to improved healthcare
processes and outcomes).
Those submitting comments are
encouraged to include a summary of
evidence for the readiness of a topic for
quality measurement and the
importance of a topic or method.
Additional background information may
be attached. Commenters may wish to
address these issues using the following
questions. Commenters may also wish
to include in their comments a summary
score based on a scale of 1–5, where 1
is a high score, 3 is a medium score, and
5 is a low score.
Validity/Underlying Scientific
Soundness: To what extent is there a
demonstrated causal relationship
between the element of quality to be
measured (as a structure, process, or
health outcome of healthcare delivery)
and another element of the healthcare
delivery system (e.g., structure and
process; process and outcome).
Commenters may wish to use as a guide
to assessing underlying scientific
soundness the method and criteria used
by the AHRQ National Advisory
Council Subcommittee on Children’s
Healthcare Quality Measures for
Medicaid and CHIP, where appropriate
PO 00000
Frm 00021
Fmt 4703
Sfmt 4703
75471
https://www.AHRQ.gov/chipra/
corebackground/
corebacktab.htm#note5).
Importance: Importance has several
dimensions:
• To what extent is the topic
important to children’s health
outcomes, family functioning, or
societal functioning, including but not
necessarily limited to high monetary
costs of poor quality healthcare to
children, families, or Society?
• To what extent is the topic
important to reducing disparities in the
quality of care for particular racial and
ethnic groups of children,
socioeconomic groups, geographically
underserved groups, and children with
special healthcare needs?
• To what extent is the topic
important as a sentinel measure that
could have spillover effects to the rest
of the children’s healthcare delivery
system?
• To what extent is the proposed
methodology important for addressing
current shortcoming of healthcare
quality measurement?
We strongly encourage comments to
be as succinct as possible (250 words or
less per topic, with additional
supporting data allowed).
3. Collection of Information
Requirements
This voluntary request does not
impose information collection and
recordkeeping requirements.
Consequently, it need not be reviewed
by the Office of Management and
Budget under the authority of the
Paperwork Reduction Act of 1995 (44
U.S.C. 35).
4. Regulatory Impact Analysis
As this notice does not meet the
significance criteria of Executive Order
12866, it was not reviewed by the Office
of Management and Budget.
Dated: November 24, 2010.
Carolyn M. Clancy,
AHRQ Director.
[FR Doc. 2010–30262 Filed 12–2–10; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Patient Safety Organizations:
Voluntary Delisting
Agency for Healthcare Research
and Quality, HHS.
ACTION: Notice of Delisting.
AGENCY:
E:\FR\FM\03DEN1.SGM
03DEN1
75472
Federal Register / Vol. 75, No. 232 / Friday, December 3, 2010 / Notices
AHRQ has accepted a
notification of voluntary relinquishment
from ORQA, LLC of its status as a
Patient Safety Organization (PSO). The
Patient Safety and Quality Improvement
Act of 2005 (Patient Safety Act), Public
Law 109–41, 42 U.S.C. 299b–21—b–26,
provides for the formation of PSOs,
which collect, aggregate, and analyze
confidential information regarding the
quality and safety of health care
delivery. The Patient Safety and Quality
Improvement Final Rule (Patient Safety
Rule), 42 CFR Part 3, authorizes AHRQ,
on behalf of the Secretary of HHS, to list
as a PSO an entity that attests that it
meets the statutory and regulatory
requirements for listing. A PSO can be
‘‘delisted’’ by the Secretary if it is found
to no longer meet the requirements of
the Patient Safety Act and Patient Safety
Rule, including when a PSO chooses to
voluntarily relinquish its status as a
PSO for any reason.
DATES: The directories for both listed
and delisted PSOs are ongoing and
reviewed weekly by AHRQ. The
delisting was effective at 12 Midnight
ET (2400) on October 13, 2010.
ADDRESSES: Both directories can be
accessed electronically at the following
HHS Web site: https://
www.pso.AHRQ.gov/.
FOR FURTHER INFORMATION CONTACT:
Diane Cousins, RPh., Center for Quality
Improvement and Patient Safety, AHRQ,
540 Gaither Road, Rockville, MD 20850;
Telephone (toll free): (866) 403–3697;
Telephone (local): (301) 427–1111; TTY
(toll free): (866) 438–7231; TTY (local):
(301) 427–1130; E-mail:
pso@AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
mstockstill on DSKH9S0YB1PROD with NOTICES
SUMMARY:
Background
The Patient Safety Act authorizes the
listing of PSOs, which are entities or
component organizations whose
mission and primary activity is to
conduct activities to improve patient
safety and the quality of health care
delivery. HHS issued the Patient Safety
Rule to implement the Patient Safety
Act. AHRQ administers the provisions
of the Patient Safety Act and Patient
Safety Rule (PDF file, 450 KB. PDF
Help) relating to the listing and
operation of PSOs. Section 3.108(d) of
the Patient Safety Rule requires AHRQ
to provide public notice when it
removes an organization from the list of
federally approved PSOs. AHRQ has
accepted a notification from ORQA,
LLC, PSO number P0013, to voluntarily
relinquish its status as a PSO.
Accordingly, ORQA, LLC was delisted
effective at 12 Midnight ET (2400) on
October 13, 2010.
VerDate Mar<15>2010
16:09 Dec 02, 2010
Jkt 223001
More information on PSOs can be
obtained through AHRQ’s PSO Web site
at https://www.pso.AHRQ.gov/
index.html.
Dated: November 24, 2010.
Carolyn M. Clancy,
Director.
[FR Doc. 2010–30263 Filed 12–2–10; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Patient Safety Organizations:
Voluntary Delisting
Agency for Healthcare Research
and Quality, HHS.
ACTION: Notice of Delisting.
AGENCY:
AHRQ has accepted a
notification of voluntary relinquishment
from Helmet Fire, Inc. Patient Safety
Group (A Component of Helmet Fire,
Inc. of its status as a Patient Safety
Organization (PSO). The Patient Safety
and Quality Improvement Act of 2005
(Patient Safety Act), Public Law 109–41,
42 U.S.C. 299b–21—b–26, provides for
the formation of PSOs, which collect,
aggregate, and analyze confidential
information regarding the quality and
safety of health care delivery. The
Patient Safety and Quality Improvement
Final Rule (Patient Safety Rule), 42 CFR
Part 3, authorizes AHRQ, on behalf of
the Secretary of HHS, to list as a PSO
an entity that attests that it meets the
statutory and regulatory requirements
for listing. A PSO can be ‘‘delisted’’ by
the Secretary if it is found to no longer
meet the requirements of the Patient
Safety Act and Patient Safety Rule,
including when a PSO chooses to
voluntarily relinquish its status as a
PSO for any reason.
DATES: The directories for both listed
and delisted PSOs are ongoing and
reviewed weekly by AHRQ. The
delisting was effective at 12 Midnight
ET (2400) on October 13, 2010.
ADDRESSES: Both directories can be
accessed electronically at the following
HHS Web site: https://
www.pso.AHRQ.gov/.
FOR FURTHER INFORMATION CONTACT:
Diane Cousins, RPh., Center for Quality
Improvement and Patient Safety, AHRQ,
540 Gaither Road, Rockville, MD 20850;
Telephone (toll free): (866) 403–3697;
Telephone (local): (301) 427–1111; TTY
(toll free): (866) 438–7231; TTY (local):
(301) 427–1130; E-mail:
pso@AHRQ.hhs.gov.
SUMMARY:
PO 00000
Frm 00022
Fmt 4703
Sfmt 4703
SUPPLEMENTARY INFORMATION:
Background
The Patient Safety Act authorizes the
listing of PSOs, which are entities or
component organizations whose
mission and primary activity is to
conduct activities to improve patient
safety and the quality of health care
delivery.
HHS issued the Patient Safety Rule to
implement the Patient Safety Act.
AHRQ administers the provisions of the
Patient Safety Act and Patient Safety
Rule (PDF file, 450 KB. PDF Help)
relating to the listing and operation of
PSOs. Section 3.108(d) of the Patient
Safety Rule requires AHRQ to provide
public notice when it removes an
organization from the list of federally
approved PSOs. AHRQ has accepted a
notification from Helmet Fire, Inc.
Patient Safety Group (A Component of
Helmet Fire, Inc., PSO number P0023, to
voluntarily relinquish its status as a
PSO. Accordingly, Helmet Fire, Inc.
Patient Safety Group (A Component of
Helmet Fire, Inc) was delisted effective
at 12 Midnight ET (2400) on October 13,
2010.
More information on PSOs can be
obtained through AHRQ’s PSO Web site
at https://www.pso.AHRQ.gov/
index.html.
Dated: November 24, 2010.
Carolyn M. Clancy,
Director.
[FR Doc. 2010–30267 Filed 12–2–10; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Patient Safety Organizations:
Voluntary Delisting
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Notice of Delisting.
AGENCY:
AHRQ has accepted a
notification of voluntary relinquishment
from Human Performance Technology
Group, Inc. of its status as a Patient
Safety Organization (PSO). The Patient
Safety and Quality Improvement Act of
2005 (Patient Safety Act), Public Law
109–41, 42 U.S.C. 299b–21—b–26,
provides for the formation of PSOs,
which collect, aggregate, and analyze
confidential information regarding the
quality and safety of health care
delivery. The Patient Safety and Quality
Improvement Final Rule (Patient Safety
Rule), 42 CFR Part 3, authorizes AHRQ,
SUMMARY:
E:\FR\FM\03DEN1.SGM
03DEN1
]]>Agencies
[Federal Register Volume 75, Number 232 (Friday, December 3, 2010)]
[Notices]
[Pages 75471-75472]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-30263]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Patient Safety Organizations: Voluntary Delisting
AGENCY: Agency for Healthcare Research and Quality, HHS.
ACTION: Notice of Delisting.
-----------------------------------------------------------------------
[[Page 75472]]
SUMMARY: AHRQ has accepted a notification of voluntary relinquishment
from ORQA, LLC of its status as a Patient Safety Organization (PSO).
The Patient Safety and Quality Improvement Act of 2005 (Patient Safety
Act), Public Law 109-41, 42 U.S.C. 299b-21--b-26, provides for the
formation of PSOs, which collect, aggregate, and analyze confidential
information regarding the quality and safety of health care delivery.
The Patient Safety and Quality Improvement Final Rule (Patient Safety
Rule), 42 CFR Part 3, authorizes AHRQ, on behalf of the Secretary of
HHS, to list as a PSO an entity that attests that it meets the
statutory and regulatory requirements for listing. A PSO can be
``delisted'' by the Secretary if it is found to no longer meet the
requirements of the Patient Safety Act and Patient Safety Rule,
including when a PSO chooses to voluntarily relinquish its status as a
PSO for any reason.
DATES: The directories for both listed and delisted PSOs are ongoing
and reviewed weekly by AHRQ. The delisting was effective at 12 Midnight
ET (2400) on October 13, 2010.
ADDRESSES: Both directories can be accessed electronically at the
following HHS Web site: https://www.pso.AHRQ.gov/.
FOR FURTHER INFORMATION CONTACT: Diane Cousins, RPh., Center for
Quality Improvement and Patient Safety, AHRQ, 540 Gaither Road,
Rockville, MD 20850; Telephone (toll free): (866) 403-3697; Telephone
(local): (301) 427-1111; TTY (toll free): (866) 438-7231; TTY (local):
(301) 427-1130; E-mail: pso@AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
Background
The Patient Safety Act authorizes the listing of PSOs, which are
entities or component organizations whose mission and primary activity
is to conduct activities to improve patient safety and the quality of
health care delivery. HHS issued the Patient Safety Rule to implement
the Patient Safety Act. AHRQ administers the provisions of the Patient
Safety Act and Patient Safety Rule (PDF file, 450 KB. PDF Help)
relating to the listing and operation of PSOs. Section 3.108(d) of the
Patient Safety Rule requires AHRQ to provide public notice when it
removes an organization from the list of federally approved PSOs. AHRQ
has accepted a notification from ORQA, LLC, PSO number P0013, to
voluntarily relinquish its status as a PSO. Accordingly, ORQA, LLC was
delisted effective at 12 Midnight ET (2400) on October 13, 2010.
More information on PSOs can be obtained through AHRQ's PSO Web
site at https://www.pso.AHRQ.gov/.
Dated: November 24, 2010.
Carolyn M. Clancy,
Director.
[FR Doc. 2010-30263 Filed 12-2-10; 8:45 am]
BILLING CODE 4160-90-M
